TyG index serves as a clinically validated surrogate marker for insulin resistance (IR), which is pathophysiologically defined as a state of diminished insulin sensitivity in key metabolic tissues including the liver, skeletal muscle, and adipose tissue, ultimately leading to impaired glucose uptake and utilization (6). This evidence concerns the gene INS and Insulin resistance.